Entries by Russell Radefeld

Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof

San Francisco, CA (September 11, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr. Stephen Sundlof will retire in January of 2018 and that, simultaneous with his retirement, Dr. Hangjun Zhan will be promoted to the position of Chief Scientific Officer. Dr. […]

Kindred Biosciences to Present at Upcoming Investor Conferences

San Francisco, CA (August 30, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will be presenting at three, upcoming investor conferences in September 2017: 6th Annual Gateway Conference (September 6-7, 2017). Location: Four Seasons Hotel, San Francisco, CA Presentation Date and […]

Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting

Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting San Francisco, CA (August 4, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will be sponsoring twenty veterinary students to attend the 2017 American Association of […]

KindredBio Announces Pricing of Public Offering

SAN FRANCISCO, July 12, 2017 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $7.50 per share, for a total offering amount of […]